Immediately after attending Abington High School, Dr. Rosenwald started his healthcare education at PSU in 1973. He excelled a business and was particularly fascinated with economics and finance. He was a member of Beta Gamma Sigma, the business school’s honors society. In 1977, he graduated with his Bachelors degree in Finance. Despite his understanding and fascination with business, Lindsay Rosenwald had always aspired to become a medical doctor.

In pursuit of his lifelong dream, Rosenwald entered Temple University’s College of Medicine. Right after graduating from Temple University in 1983, he began an internship at Abington Hospital before beginning his own private practice. After completing his internship, he worked as being a medical professional in his private practice for 2.5 years. Although he really enjoyed practicing medicine Dr. Rosenwald seemed as if something was absent. He decided he needed to combine his 2 pursuits, business and medicinal drugs, and look for a career that would let him pursue those passions.

Rosenwald left his private practice in 1986 to head to Wall Street where he took on a position as a Physician / Analyst, a very unique position with just a few individuals doing it at the time. Despite the fact that some doubted if he could flourish in this placement, he showed those that doubted him that he was very proficient at investments. He had a passion for growing investment capital available to the health care sector and that is primarily why he worked there. He received great admiration in his new position, and even though he missed his old private practice, he realized this is where he actually belonged. During this time, he also worked for DH Blair and Company, a private investment organization, as the managing director of corporate finance. After a few years, he left D.H. Blair and Company to focus on a new venture and firm.

Lindsay Rosenwald , founder of Paramount Biotech, made it successful by acquiring other biotech businesses and making them an element of his portfolio. The organization has financed more than two dozen companies within the last 3 years. He creates these businesses by focusing on the growth of both corporate and biotechnology portions. Now, Paramount Capital is comprised of many companies. These companies include Paramount Biosciences, which generates and facilitates new biotechnology businesses, Paramount Corporate Development, which actively works to build the Paramount Corporation as well as create brand new drugs, and Paramount BioCapital, a broker-dealer that has raised over $950 billion in profit since it started. The businesses that Rosenwald handles have licensed or obtained over one hundred experimental stage drugs.

Possibly one of Dr Lindsay Rosenwald‘s greatest successes is that he set the record for the quickest development of a drug. In only thirty months, Arsenic Trioxide was created and authorized by the FDA for treating a deadly type of leukemia. This medication has been on the market throughout the world for over a decade and it has saved and prolonged thousands of lives.

Rosenwald has been revolutionary with the businesses he has developed. One of his companies sold to J&J for over One Billion Dollars even though they only had 1 medication with phase 2 data. He has also founded the very first publicly traded stem cell company, gene therapy company, and cancer vaccine firm. As Rosenwald as the director, his businesses have created many of the most valuable and groundbreaking drug treatments of the 21st century. He is also accountable for the first successful anti-obesity medication created in the usa marketplace in 30 years.

One of the reasons that Rosenwald’s businesses are profitable is that he hires PhDs, MDs, MBAs, and various other experts to function as his senior level professionals. These people usually have experience in business, however they also tend to possess great knowledge in the medical world. They strive to develop new medicines with great focus and efficiency. A few of these medicines have the potential to alter the way we look at medical science entirely today. He has also created the Rosenwald Foundation that has donated millions of dollars to healthcare and science instruction to help build the future of medical science.

Lots of people attribute the achievement of the biotech industry on a whole to Dr. Rosenwald. His visionary firms have altered many lives and made Dr. Rosenwald’s individual assets soar to the tune of $600 million.